Hemoglobin A1c and race: Should therapeutic targets and diagnostic cutoffs differ among racial groups?

Clinical Chemistry

Volumn 62, Issue 9, 2016, Pages 1199-1201

  Sacks, David B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

BLACK PERSON; CAUCASIAN; EAST ASIAN; ENZYME ACTIVITY; ERYTHROCYTE LIFESPAN; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCATION; GLYCEMIC CONTROL; HEREDITY; HISPANIC; HUMAN; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; ORAL GLUCOSE TOLERANCE TEST; RACE DIFFERENCE; ANALYSIS; ANCESTRY GROUP; BLOOD; ETHNOLOGY;

BLOOD GLUCOSE; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; GLYCATED HEMOGLOBIN A; HUMANS;

EID: 84985994118     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.255166     Document Type: Note

References (15)

1. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33 Suppl 1:S11-61.
2. Little RR, Rohlfing CL, Sacks DB. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205-14.
3. Welsh KJ, Kirkman MS, Sacks DB. Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions. Diabetes Care. 2016;39:1299-306.
4. Kirk JK, D'Agostino RB Jr, Bell RA, Passmore LV, Bonds DE, Karter AJ, Narayan KM. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006;29:2130-6.
5. Kirk JK, Passmore LV, Bell RA, Narayan KM, D'Agostino RB, Jr., Arcury TA, Quandt SA. Disparities in A1c levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2008;31: 240-6.
6. Herman WH. Are there clinical implications of racial differences in HbA1c? Yes, to not consider can do great harm. Diabetes Care. 2016;39:1458-61.
7. Selvin E. Counterpoint-are there clinical implications of racial differences in HbA1c? A difference, to be a difference, must make a difference. Diabetes Care. 2016;39: 1462-7.
8. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
9. Sacks DB, Nathan DM, Lachin JM. Gaps in the glycation gap hypothesis. Clin Chem 2011;57:150-2.
10. Leong A, Meigs JB. Type 2 diabetes prevention: implications of hemoglobin A1c genetics. Rev Diabet Stud 2015;12:351-62.
11. The International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32: 1327-34.
12. Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB, Narayan KM. A1c cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010;33:515-9.
13. Tsugawa Y, Takahashi O, Meigs JB, Davis RB, Imamura F, Fukui T, et al. New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes 2012;61:3280-4.
14. Collaboration NCDRF. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol 2015;3:624-37.
15. Sacks DB. A1c versus glucose testing: a comparison. Diabetes Care 2011;34:518-23.